Emerging concepts in cancer therapy: Mechanisms of resistance.
作者信息
Gupta Seema, Verma Vivek, Dwarakanath Bilikere S
机构信息
The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA.
The Hormel Institute, Masonic Cancer Center, University of Minnesota, Austin, Minnesota, USA.
出版信息
Cancer Rep (Hoboken). 2022 Dec;5(12):e1715. doi: 10.1002/cnr2.1715. Epub 2022 Sep 9.
Abstract
摘要
相似文献
1
Emerging concepts in cancer therapy: Mechanisms of resistance.癌症治疗的新观念：耐药机制
Cancer Rep (Hoboken). 2022 Dec;5(12):e1715. doi: 10.1002/cnr2.1715. Epub 2022 Sep 9.
2
The role of signal transduction in cancer treatment and drug resistance.信号转导在癌症治疗和耐药性中的作用。
Eur J Surg Oncol. 2002 Sep;28(6):679-84. doi: 10.1053/ejso.2002.1303.
3
The dynamic control of signal transduction networks in cancer cells.癌细胞中信号转导网络的动态控制。
Nat Rev Cancer. 2015 Sep;15(9):515-27. doi: 10.1038/nrc3983. Epub 2015 Aug 20.
4
Is the cancer stem cell population "a player" in multi-drug resistance?癌症干细胞群体在多药耐药中是“参与者”吗？
Acta Pol Pharm. 2008 Jul-Aug;65(4):493-500.
5
[Cancer targeted therapy and resistance signals].[癌症靶向治疗与耐药信号]
Seikagaku. 2013 Jun;85(6):475-83.
6
Drug resistance to targeted therapies: déjà vu all over again.对靶向治疗的耐药性：似曾相识的感觉再次出现。
Mol Oncol. 2014 Sep 12;8(6):1067-83. doi: 10.1016/j.molonc.2014.05.004. Epub 2014 May 21.
7
Roles and mechanisms of adipokines in drug resistance of tumor cells.脂肪细胞因子在肿瘤细胞耐药中的作用及其机制。
Eur J Pharmacol. 2021 May 15;899:174019. doi: 10.1016/j.ejphar.2021.174019. Epub 2021 Mar 13.
8
Editorial: Resistance to Endocrine Therapies in Cancer.社论：癌症内分泌治疗的耐药性
Front Endocrinol (Lausanne). 2020 Apr 9;11:196. doi: 10.3389/fendo.2020.00196. eCollection 2020.
9
Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.逃避肿瘤的逃避：抗血管生成癌症治疗的当前概念和观点。
Drug Resist Updat. 2010 Feb-Apr;13(1-2):16-28. doi: 10.1016/j.drup.2009.12.001. Epub 2010 Jan 12.
10
The role of signal transduction pathways in drug and radiation resistance.信号转导通路在药物和辐射抗性中的作用。
Cancer Treat Res. 2002;112:89-108. doi: 10.1007/978-1-4615-1173-1_5.
引用本文的文献
1
Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines.转录组分析揭示了肺腺癌细胞系中与靶向治疗内在抗性相关的早期改变。
Cancers (Basel). 2024 Jul 8;16(13):2490. doi: 10.3390/cancers16132490.
2
Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis.倍半萜内酯作为新兴生物分子，通过靶向细胞凋亡来抑制癌症。
Front Pharmacol. 2024 Mar 11;15:1371002. doi: 10.3389/fphar.2024.1371002. eCollection 2024.
本文引用的文献
1
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.三阴性乳腺癌：关于流行病学、危险因素、信号通路、治疗及人工智能作用的简要综述
Front Mol Biosci. 2022 Jan 25;9:836417. doi: 10.3389/fmolb.2022.836417. eCollection 2022.
2
Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer.组蛋白去乙酰化酶抑制剂通过靶向辐射诱导的上游刺激因子-1 逆转前列腺癌的放射抵抗。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1553. doi: 10.1002/cnr2.1553. Epub 2021 Sep 17.
3
Radiosensitization of calreticulin-overexpressing human glioma cell line by the polyphenolic acetate 7, 8-diacetoxy-4-methylcoumarin.表没食子儿茶素没食子酸酯对高表达钙网蛋白的人脑胶质瘤细胞系的放射增敏作用。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1326. doi: 10.1002/cnr2.1326. Epub 2021 Sep 2.
4
Drug resistance and combating drug resistance in cancer.癌症中的耐药性与抗耐药性
Cancer Drug Resist. 2019;2(2):141-160. doi: 10.20517/cdr.2019.10. Epub 2019 Jun 19.
5
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.靶向癌症治疗中的小分子：进展、挑战和未来展望。
Signal Transduct Target Ther. 2021 May 31;6(1):201. doi: 10.1038/s41392-021-00572-w.
6
Angiogenesis as a hallmark of solid tumors - clinical perspectives.血管生成作为实体瘤的一个标志——临床观点。
Cell Oncol (Dordr). 2021 Aug;44(4):715-737. doi: 10.1007/s13402-021-00602-3. Epub 2021 Apr 9.
7
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.肿瘤微环境驱动的肿瘤治疗耐药性的适应性机制
Front Cell Dev Biol. 2021 Mar 1;9:641469. doi: 10.3389/fcell.2021.641469. eCollection 2021.
8
Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies.血管选择和血管生成拟态介导了对血管生成抑制策略的抵抗。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1318. doi: 10.1002/cnr2.1318. Epub 2020 Dec 9.
9
Role of eIF4A1 in triple-negative breast cancer stem-like cell-mediated drug resistance.eIF4A1 在三阴性乳腺癌干细胞样细胞介导的耐药中的作用。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1299. doi: 10.1002/cnr2.1299. Epub 2020 Oct 14.
10
Molecular and cellular paradigms of multidrug resistance in cancer.癌症多药耐药性的分子和细胞模式。
Cancer Rep (Hoboken). 2022 Dec;5(12):e1291. doi: 10.1002/cnr2.1291. Epub 2020 Oct 13.
Zotero 插件